Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

[Northerner]

Researchers from Massachusetts Eye and Ear and Schepens Eye Research Institute have shown an association between a defective myogenic response -- the regulatory increase or decrease in blood pressure to keep blood flow within the vessels of the retina constant -- and early, accelerated development of retinopathy in patients with type 1 diabetes. These findings, published online today inInvestigative Ophthalmology and Visual Science, identify one mechanism to explain why some patients develop diabetic retinopathy sooner than others. Furthermore, the findings provide a target for future study, which may lead to therapies to delay or prevent the development of accelerated onset diabetic retinopathy.

https://www.sciencedaily.com/releases/2016/04/160401220709.htm